TrialAnnals of the rheumatic diseases2014

Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension.

Edward Keystone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.